K. Nevasaari

FEC (5-fluorouracil-epirubicin-cyclophosphamide) monthly versus FEC weekly in metastatic breast cancer. First results of a randomized trial.

C. Blomqvist, P. Hietanen, I. Elomaa, 1992, Acta oncologica.

TAMOXIFEN AND THROMBOSIS

P. Taskinen, M. Heikkinen, K. Nevasaari, 1978, The Lancet.

Immunoblastic lymphadenopathy with a high serum yersinia enterocolitica titer. A case report

T. Karttunen, M. Alavaikko, P. Taskinen, 1983, Cancer.

Effects of various in vitro--inhibitors of benzo(a)pyrene metabolism in isolated rat lung perfusion.

K. Vähäkangas, O. Pelkonen, N. Kärki, 2009, Acta pharmacologica et toxicologica.

The metabolism of benzo(a)pyrene in isolated perfused lungs from variously-treated rats.

K. Vähäkangas, O. Pelkonen, N. Kärki, 2009, Acta pharmacologica et toxicologica.

Effect of atropine on bile flow and biliary excretion of 3H-ouabain in the isolated perfused rat liver.

B. Alakare, N. Kärki, K. Nevasaari, 1977, Pharmacology.

A simple membrane oxygenator for the isolated rat liver perfusion

K. Nevasaari, 1976, Experientia.

THE DISPOSITION OF BENZO(A)PYRENE IN ISOLATED PERFUSED RAT LUNG

K. Vähäkangas, O. Pelkonen, N. Kärki, 1977 .

Surgical treatment of intestinal radiation injury

M. Kairaluoma, J. Mäkelä, K. Nevasaari, 1987, Journal of surgical oncology.

Influence of treatment schedule on toxicity and efficacy of cyclophosphamide, epirubicin, and fluorouracil in metastatic breast cancer: a randomized trial comparing weekly and every-4-week administration.

C. Blomqvist, P. Hietanen, I. Elomaa, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Different effects of microsomal enzyme inducers on the biliary excretion of digoxin.

B. Alakare, N. Kärki, K. Nevasaari, 2009, Acta pharmacologica et toxicologica.